Inflammatory State

CHICAGO — In patients with metastatic non-clear cell renal cell carcinoma, a high systemic inflammatory state at baseline was associated with worse outcomes after treatment with atezolizumab and bevacizumab, according to a poster presented at ASCO Annual Meeting.

NEW ORLEANS — In high-risk patients on statin therapy, residual inflammatory risk as assessed by high-sensitivity C-reactive protein better predicted CV events and death than residual cholesterol risk as assessed by LDL, data show.